Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tefron Ltd. Regulatory Filings 2006

Apr 30, 2006

7077_rns_2006-04-30_a83e41ed-4e4b-4c01-993f-eafa4347de6a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

---BEGIN PRIVACY-ENHANCED MESSAGE---

Proc-Type: 2001,MIC-CLEAR

Originator-Name: [email protected]

Originator-Key-Asymmetric: MfgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB

MIC-Info: RSA-MD5, RSA, O/dCLFpPwkntvw3mJgFGc5LFRS6HmTZol66M27RyGNqBhkq5vjepjD5S6AjHplXw K1UkpKzNcpp5OD2xxoiE1A==

0001188112-06-001215.txt : 20060427 0001188112-06-001215.hdr.sgml : 20060427 20060427124054 accession number: 0001188112-06-001215 conformed submission type: 6-K public document count: 2 conformed period of report: 20060430 filed as of date: 20060427 date as of change: 20060427

FILER:

COMPANY DATA: COMPANY CONFORMED NAME: TEFRON LTD CENTRAL INDEX KEY: 0001044863 STANDARD INDUSTRIAL CLASSIFICATION: WOMEN'S, MISSES', CHILDREN'S & INFANTS' UNDERGARMENTS [2340] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231

FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14680 FILM NUMBER: 06784030

BUSINESS ADDRESS: STREET 1: 28 CHIDA ST STREET 2: ISRAEL CITY: BNEI BRAK ZIP: 51371

MAIL ADDRESS: STREET 1: 28 CHIDA ST STREET 2: ISRAEL CITY: BNEI BRAK ZIP: 51371


SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of The Securities Exchange Act of 1934

For the month of April, 2006

TEFRON LTD. (Translation of registrant's name into English)

IND. CENTER TERADYON, P.O. BOX 1365, MISGAV 20179, ISRAEL (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☑ Form 40-F ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☑

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- N/A

Attached hereto and incorporated by reference herein is a press release, dated April 27, 2006.

This Form 6-K is hereby incorporated by reference into Tefron Ltd.'s Registration Statement on Form F-3 (Registration No. 333-128847) and its Registration Statement on Form S-8 (Registration No. 333-111932).


2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TEFRON LTD.

(Registrant)

By: /s/ Asaf Alperovitz

Name: Asaf Alperovitz Title: Chief Financial Officer

By: /s/ Hanoch Zlotnik

Name: Hanoch Zlotnik Title: Finance Manager

Date: April 27, 2006

3


news

TEFRON ANNOUNCES CLOSING OF SALE OF ITS ALBAHEALTH INTEREST

MISGAV, ISRAEL, APRIL 27, 2006 -- Tefron Ltd. (NYSE:TFR; TASE:TFRN), a leading producer of seamless intimate apparel and engineered-for-performance (EFPTM) active wear, today announced that it has closed the sale to AlbaHealth LLC of its ownership interest in AlbaHealth, which manufactures and sells textile healthcare products.

Under the terms of the transaction, Tefron will receive aggregate consideration of approximately $13 million, consisting of approximately $10 million payable in cash and $3 million pursuant to the terms of an unsecured subordinated promissory note, the principal amount of which will be due August 31, 2009. The note will bear annual interest at LIBOR plus 3%, and the payment of the note will be subordinated in favor of AlbaHealth's senior bank lenders.

Yos Shiran, Tefron's Chief Executive Officer, said: "I am pleased with this strategic step. The transaction will allow us to better focus our efforts on our core businesses - intimate apparel, active wear and swim wear. The completion of the transaction will also improve our balance sheet by reducing debt and increasing cash."

ABOUT TEFRON

Tefron manufactures boutique-quality everyday seamless intimate apparel, active wear and swim wear sold throughout the world by such name-brand marketers as Victoria's Secret, Nike, The Gap, Banana Republic, Target, Warnaco/Calvin Klein, Patagonia, Reebok and El Corte Englese, as well as other well known retailers and designer labels. The company's product line includes knitted briefs, bras, tank tops, boxers, leggings, crop, T-shirts, nightwear, bodysuits, swim wear, beach wear and active-wear. The Company's Healthcare Division manufactures and sells a range of textile healthcare products.


THIS PRESS RELEASE CONTAINS CERTAIN FORWARD-LOOKING STATEMENTS WITH RESPECT TO THE COMPANY'S BUSINESS, FINANCIAL CONDITION AND RESULTS OF OPERATIONS. THESE FORWARD LOOKING STATEMENTS ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTEMPLATED IN SUCH FORWARD-LOOKING STATEMENTS, INCLUDING, BUT NOT LIMITED TO, FLUCTUATIONS IN PRODUCT DEMAND, CHANGING ECONOMIC CONDITIONS, LOWER PRICES AS WELL AS CERTAIN OTHER RISKS DETAILED FROM TIME TO TIME IN THE COMPANY'S FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY RELEASE ANY REVISIONS TO THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER THE DATE HEREOF OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED.

COMPANY CONTACT


IR CONTACT


Asaf Alperovitz Chief Financial Officer +972-4-9900803 [email protected] </TEXT> </DOCUMENT> </SEC-DOCUMENT>